Fang Li

Fang is a postdoctoral researcher in pharmacoepidemiology in the Brain Informatics Group at the Department of Psychiatry, University of Oxford, funded under the SMARTbiomed project.

Her main research focuses on drug repurposing. She combines large-scale electronic health record data with target-trial emulation, marginal structural models, and other causal-inference methods to identify approved medications with novel therapeutic potential, and to estimate real-world treatment effects at multi-million-patient scale. She applies these approaches to understanding pharmacological mechanisms underlying complex brain disorders, particularly psychiatric conditions (depression, anxiety, bipolar disorder, psychosis) and dementia. Prior to joining Oxford, Fang received her PhD in health economics and epidemiology from the University of Groningen (the Netherlands).